Divi's Labs up 21% as USFDA to lift import alert on Vizag unit

Shares of Divi's Laboratories today zoomed over 21 per cent after it said the US health regulator will lift an import alert imposed on the company's Unit-II in Visakhapatnam.
The stock soared 21.37 per cent to Rs 1,117 on BSE.
At NSE, shares of the company jumped 20.99 per cent to Rs 1,117.60.
In terms of equity volume, 10 lakh shares of the company were traded on BSE and over 85 lakh shares changed hands at NSE during the morning trade.
Divi's Laboratories today said the US health regulator will lift an import alert imposed on the company's Unit-II in Visakhapatnam and is moving to close out the warning letter issued to the unit.

The company "has been informed by the United States Food and Drug Administration (USFDA) that it will be lifting the Import Alert 66-40 and move to close out the warning letter issued to the company's Unit-II at Visakhapatnam", Divi's Laboratories said in a filing to BSE.
It, however, did not share any details and timelines for resolution of the matter.
Earlier in July, the company announced that USFDA had moved to lift Import Alert 99-32 imposed on the unit.